The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023

BACKGROUND: During the first year of the COVID-19 pandemic, the proportion of reported cases of COVID-19 among Canadians was under 6%. Although high vaccine coverage was achieved in Canada by fall 2021, the Omicron variant caused unprecedented numbers of infections, overwhelming testing capacity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Tanya J., Swail, Hanna, Jain, Jaspreet, Anderson, Maureen, Awadalla, Philip, Behl, Lesley, Brown, Patrick E., Charlton, Carmen L., Colwill, Karen, Drews, Steven J., Gingras, Anne-Claude, Hinshaw, Deena, Jha, Prabhat, Kanji, Jamil N., Kirsh, Victoria A., Lang, Amanda L.S., Langlois, Marc-André, Lee, Stephen, Lewin, Antoine, O’Brien, Sheila F., Pambrun, Chantale, Skead, Kimberly, Stephens, David A., Stein, Derek R., Tipples, Graham, Van Caeseele, Paul G., Evans, Timothy G., Oxlade, Olivia, Mazer, Bruce D., Buckeridge, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426348/
https://www.ncbi.nlm.nih.gov/pubmed/37580072
http://dx.doi.org/10.1503/cmaj.230249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426348/
https://www.ncbi.nlm.nih.gov/pubmed/37580072
http://dx.doi.org/10.1503/cmaj.230249

Ejemplares similares